Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer, Study Suggests
Friday, May 1, 2009 - 10:35
in Health & Medicine
A drug widely used to treat type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users. Sitagliptin, sold in pill form as Januvia, caused abnormalities in the pancreas that are recognized as risk factors for pancreatitis and, with time, pancreatic cancer in humans.